Considerations on the restriction of Assisted Reproductive Technology (ART) due to COVID-19.
Semin Perinatol
; 44(7): 151288, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1028640
ABSTRACT
The rapid rise of novel coronavirus disease 2019 (COVID-19) cases led the American Society for Reproductive Medicine (ASRM) to recommend immediate cessation of all new fertility treatment cycles on March 17, 2020. Controversial from the start, providers and patients expressed their opposition through online petitions, surveys, and other forums. While the impact of a delay in access to reproductive care is unknown, previous studies are reassuring that a delay in the timespan of months may not affect clinical outcomes. However, dropout from care during this pandemic remains a serious concern. Effective therapies against the virus and a vaccine are not on the immediate horizon. Accepting COVID-19 will likely be a part of our lives for the near future necessitates the modification of fertility protocols to keep patients, providers, and staff as safe as possible. We believe fertility treatment is an urgent, essential service that can be performed safely and responsibly during this pandemic.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Guías de Práctica Clínica como Asunto
/
Técnicas Reproductivas Asistidas
/
Atención a la Salud
/
Tiempo de Tratamiento
/
COVID-19
/
Infertilidad
Tipo de estudio:
Estudios diagnósticos
/
Estudio observacional
/
Estudio pronóstico
/
Investigación cualitativa
Tópicos:
Vacunas
Límite:
Femenino
/
Humanos
País/Región como asunto:
America del Norte
Idioma:
Inglés
Revista:
Semin Perinatol
Año:
2020
Tipo del documento:
Artículo
País de afiliación:
J.semperi.2020.151288
Similares
MEDLINE
...
LILACS
LIS